Zenolution, IPO Price Set at 14,000 Won... "Listing on KOSDAQ on the 24th"

[Asia Economy Reporter Hyunseok Yoo] Genolution, which is preparing for a transfer listing on KOSDAQ, announced on the 14th that the public offering price was set at 14,000 KRW, the upper limit of the desired public offering band (12,000 to 14,000 KRW), based on the demand forecast conducted for institutional investors on the 8th and 9th.

According to the company, a total of 1,206 institutional investors participated in this demand forecast, recording a competition rate of 1,161 to 1. The total public offering amount is 11.2 billion KRW.

A Genolution official stated, “100% of the participating institutions offered prices at or above the upper limit of the desired public offering band, 14,000 KRW,” adding, “851 institutions, accounting for over 70%, offered prices exceeding 14,000 KRW, showing a strong response from domestic and international institutions.”

Kim Ki-ok, CEO of Genolution, said, “The public offering price was finalized within the desired band to maximize investors' profits,” and added, “We will keep our promise to become a global leader in the gene field through continuous research and development.”

Meanwhile, the subscription for general investors for Genolution’s public offering will be held over two days from today until the 15th. Subscriptions can be made through the lead underwriter, Shin Young Securities. The scheduled KOSDAQ listing date is the 24th.

This content was produced with the assistance of AI translation services.